MARKET

BHVN

BHVN

Biohaven
NYSE
13.88
-0.81
-5.51%
After Hours: 13.82 -0.06 -0.42% 19:58 10/23 EDT
OPEN
15.22
PREV CLOSE
14.69
HIGH
15.37
LOW
13.83
VOLUME
4.69M
TURNOVER
--
52 WEEK HIGH
18.57
52 WEEK LOW
7.48
MARKET CAP
2.10B
P/E (TTM)
-2.9884
1D
5D
1M
3M
1Y
5Y
1D
Biohaven Ltd. (BHVN) Receives a Buy from Canaccord Genuity
TipRanks · 1d ago
RBC Capital Sticks to Its Hold Rating for Biohaven Ltd. (BHVN)
TipRanks · 1d ago
Biohaven price target raised to $22 from $19 at RBC Capital
TipRanks · 1d ago
Biohaven price target raised to $48 from $42 at Baird
TipRanks · 1d ago
Biohaven Stock Soars As FDA Accepts Vyglyxia Resubmission - This Plot Is Too Thick For Me
Seeking Alpha · 2d ago
Midday Fly By: Meta, Tesla slipping after quarterly reports
TipRanks · 2d ago
Biohaven surges as FDA accepts resubmission for Vyglxia for spinocerebellar ataxia
Seeking Alpha · 2d ago
Why Is Biohaven Stock (BHVN) Up 34% Today?
TipRanks · 2d ago
More
About BHVN
Biohaven Ltd. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments in key therapeutic areas, including immunology, neuroscience, and oncology. It is advancing its portfolio of therapeutics, leveraging its drug development experience and multiple proprietary drug development platforms. Its clinical and preclinical programs include Kv7 ion channel modulation for epilepsy; Molecular Degrader of Extracellular Proteins (MoDE) and Targeted Removal of Aberrant Protein (TRAP) extracellular protein degradation for immunological diseases; and myostatin-activin pathway targeting agent for neuromuscular and metabolic diseases, including obesity. Its pipeline includes TYK2/JAK1 Inhibitor (brain-penetrant), IgG Degrader, Gd-IgA1 TRAP Degrader, Taldefgrobep Alfa, Kv7 Activator, TRPM3 Antagonist FGFR3 ADC, CD30 ADC, Trop2 ADC +/- PD1, and others. Its advanced product candidate from its glutamate receptor antagonist platform is troriluzole.

Webull offers Biohaven Ltd stock information, including NYSE: BHVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BHVN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BHVN stock methods without spending real money on the virtual paper trading platform.